If metformin doesn’t work well enough on its own, a GLP-1 RA is often added to the treatment plan. When a GLP-1 RA is prescribed along with insulin, it can increase the odds of hypoglycemia.

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with type 2 diabetes is linked to a reduced risk of developing certain hematologic cancers compared to insulin and metformin.

insulin and 50,590 to compare GLP-1s and metformin. Singh noted he was particularly interested in potential associations between GLP-1 use and clonal hematopoiesis of indeterminate potential (CHIP ...

In total, the researchers identified more than 1.6 million T2D patients. Of these, 51,617 received GLP-1RAs, 938,602 received insulin, and 611,115 received metformin. The average prescription ...

The study included patients with T2D prescribed a GLP-1 RA, insulin, or metformin between April 30, 2005, and October 31, 2023 (51,617; 611,115; and 938,602 patients, respectively). Groups were ...